MedaRed's Seed Round

MedaRed raised a round of funding on October 26, 2018. Investors include National Multiple Sclerosis Society.

MedaRed is developing an antibody that has shown promise in preclinical studies as a potential treatment to protect the nervous system from MS damage.…

Articles about MedaRed's Seed Round: